Literature DB >> 21877930

Agar disk diffusion and automated microbroth dilution produce similar antimicrobial susceptibility testing results for Salmonella serotypes Newport, Typhimurium, and 4,5,12:i-, but differ in economic cost.

Karin Hoelzer1, Kevin J Cummings, Lorin D Warnick, Ynte H Schukken, Julie D Siler, Yrjo T Gröhn, Margaret A Davis, Tom E Besser, Martin Wiedmann.   

Abstract

Data generated using different antimicrobial testing methods often have to be combined, but the equivalence of such results is difficult to assess. Here we compared two commonly used antimicrobial susceptibility testing methods, automated microbroth dilution and agar disk diffusion, for 8 common drugs, using 222 Salmonella isolates of serotypes Newport, Typhimurium, and 4,5,12:i-, which had been isolated from clinical salmonellosis cases among cattle and humans. Isolate classification corresponded well between tests, with 95% overall category agreement. Test results were significantly negatively correlated, and Spearman's correlation coefficients ranged from -0.98 to -0.38. Using Cox's proportional hazards model we determined that for most drugs, a 1 mm increase in zone diameter resulted in an estimated 20%-40% increase in the hazard of growth inhibition. However, additional parameters such as isolation year or serotype often impacted the hazard of growth inhibition as well. Comparison of economical feasibility showed that agar disk diffusion is clearly more cost-effective if the average sample throughput is small but that both methods are comparable at high sample throughput. In conclusion, for the Salmonella serotypes and antimicrobial drugs analyzed here, antimicrobial susceptibility data generated based on either test are qualitatively very comparable, and the current published break points for both methods are in excellent agreement. Economic feasibility clearly depends on the specific laboratory settings, and disk diffusion might be an attractive alternative for certain applications such as surveillance studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21877930      PMCID: PMC3263306          DOI: 10.1089/fpd.2011.0933

Source DB:  PubMed          Journal:  Foodborne Pathog Dis        ISSN: 1535-3141            Impact factor:   3.171


  34 in total

1.  Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.

Authors:  M A Pfaller; D J Diekema; L Boyken; S A Messer; S Tendolkar; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 2.  Setting and revising antibacterial susceptibility breakpoints.

Authors:  John Turnidge; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994.

Authors:  J M Ramos; J M Alés; M Cuenca-Estrella; R Fernández-Roblas; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

4.  Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure.

Authors:  M R Jacobs; S Bajaksouzian; E L Palavecino-Fasola; H M Holoszyc; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Characterization of Salmonella Typhimurium of animal origin obtained from the National Antimicrobial Resistance Monitoring System.

Authors:  S Zhao; P J Fedorka-Cray; S Friedman; P F McDermott; R D Walker; S Qaiyumi; S L Foley; S K Hubert; S Ayers; L English; D A Dargatz; B Salamone; D G White
Journal:  Foodborne Pathog Dis       Date:  2005       Impact factor: 3.171

6.  Evolution of multiresistance in nontyphoid salmonella serovars from 1984 to 1998 in Argentina.

Authors:  Betina E Orman; Silvia A Piñeiro; Sonia Arduino; Marcelo Galas; Roberto Melano; Maria I Caffer; Daniel O Sordelli; Daniela Centrón
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  To test or not to test: a cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemias.

Authors:  Curtis D Collins; Gregory A Eschenauer; Susan L Salo; Duane W Newton
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

8.  Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.

Authors:  Ronald N Jones; William A Craig; Paul G Ambrose; Michael N Dudley; Sudha Pottumarthy
Journal:  Diagn Microbiol Infect Dis       Date:  2005-07       Impact factor: 2.803

9.  Evaluation and use of a micro-broth dilution procedure for testing sensitivity of fermentative avian mycoplasmas to antibiotics.

Authors:  K G Whithear; D D Bowtell; E Ghiocas; K L Hughes
Journal:  Avian Dis       Date:  1983 Oct-Dec       Impact factor: 1.577

10.  Cost analysis and antimicrobial susceptibility testing comparing the E test and the agar dilution method in Campylobacter jejuni and Campylobacter coli.

Authors:  Alfonso Valdivieso-García; Ryan Imgrund; Anne Deckert; Betsy Marie Varughese; Kathleen Harris; Natalie Bunimov; Richard Reid-Smith; Scott McEwen
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10       Impact factor: 2.803

View more
  13 in total

1.  Effect of heifer-raising practices on E. coli antimicrobial resistance and Salmonella prevalence in heifer raisers.

Authors:  R V Pereira; J D Siler; K J Cummings; M A Davis; L D Warnick
Journal:  Epidemiol Infect       Date:  2015-04-23       Impact factor: 2.451

Review 2.  The Age of Next-Generation Therapeutic-Microbe Discovery: Exploiting Microbe-Microbe and Host-Microbe Interactions for Disease Prevention.

Authors:  Nathan Cruz; George A Abernathy; Armand E K Dichosa; Anand Kumar
Journal:  Infect Immun       Date:  2022-04-06       Impact factor: 3.609

3.  Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves.

Authors:  R V Pereira; J D Siler; J C Ng; M A Davis; Y T Grohn; L D Warnick
Journal:  J Dairy Sci       Date:  2014-10-11       Impact factor: 4.034

4.  Effect of preweaned dairy calf housing system on antimicrobial resistance in commensal Escherichia coli.

Authors:  R V Pereira; J D Siler; J C Ng; M A Davis; L D Warnick
Journal:  J Dairy Sci       Date:  2014-10-11       Impact factor: 4.034

5.  Antibiotic resistance among Escherichia coli and Salmonella isolated from dairy cattle feces in Texas.

Authors:  Rosine Manishimwe; Paola M Moncada; Marie Bugarel; H Morgan Scott; Guy H Loneragan
Journal:  PLoS One       Date:  2021-05-07       Impact factor: 3.240

6.  A meta-analysis of the proportion of animal Salmonella isolates resistant to drugs used against human salmonellosis in Ethiopia.

Authors:  Getachew Tadesse
Journal:  BMC Infect Dis       Date:  2015-02-21       Impact factor: 3.090

7.  In vivo selection of resistant E. coli after ingestion of milk with added drug residues.

Authors:  Richard Van Vleck Pereira; Julie D Siler; Rodrigo Carvalho Bicalho; Lorin D Warnick
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

8.  Secondary metabolites from Bacillus amyloliquefaciens isolated from soil can kill Burkholderia pseudomallei.

Authors:  Patcharaporn Boottanun; Chotima Potisap; Julian G Hurdle; Rasana W Sermswan
Journal:  AMB Express       Date:  2017-01-04       Impact factor: 3.298

9.  Burkholderia pseudomallei-absent soil bacterial community results in secondary metabolites that kill this pathogen.

Authors:  Chotima Potisap; Md Abdul Wadud Khan; Atcha Boonmee; Jorge L M Rodrigues; Surasakdi Wongratanacheewin; Rasana W Sermswan
Journal:  AMB Express       Date:  2018-08-24       Impact factor: 3.298

10.  Hotspot mutations and ColE1 plasmids contribute to the fitness of Salmonella Heidelberg in poultry litter.

Authors:  Adelumola Oladeinde; Kimberly Cook; Alex Orlek; Greg Zock; Kyler Herrington; Nelson Cox; Jodie Plumblee Lawrence; Carolina Hall
Journal:  PLoS One       Date:  2018-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.